Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Lung Neoplasms 4Thromboembolism 2Carcinoma, Non-Small-Cell Lung 2Venous Thrombosis 1Venous Thromboembolism 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pulmonary Embolism 1Prostatic Neoplasms 1Hemorrhage 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 6Gemcitabine 6Psychiatric Rehabilitation 5Early Intervention, Educational 5Cisplatin 5Cetuximab 5cediranib 4Oxaliplatin 4Magnetic Resonance Spectroscopy 4Leucovorin 4Fluorouracil 4Carboplatin 4Bevacizumab 4Trastuzumab 3Standard of Care 3Radiotherapy 3Pemetrexed 3Paclitaxel 3Methods 3Irinotecan 3Erlotinib Hydrochloride 3Docetaxel 3trametinib 2X-Rays 2Specimen Handling 2Mental Status and Dementia Tests 2Interleukin-12 Subunit p35 2Fluorodeoxyglucose F18 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Dalteparin × Thoracic × Clear all
NCT00003674 2016-07-13

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
141 enrolled
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡